Seoulin Bioscience Co.,Ltd. announced that it expects to receive KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors
November 21, 2021
Share
Seoulin Bioscience Co.,Ltd. announced a private placement of series 2 unregistered coupon nonguaranteed private placement of convertible bonds for gross proceeds of KRW 30,000,000,000 on November 22, 2021. The transaction included participation from Time Folio KOSDAQ Venture It's Time-MS No. 2 General Private Equity Trust for KRW 1,200,000,000, Time Folio It's Time-Mezzanine I General Private Equity Trust for KRW 300,000,000, Time Folio It's Time-MG 2nd General Private Equity Trust for KRW 500,000,000, IBKC Time Folio Mezzanine Blind No. 1 New Technology Fund for KRW 1,500,000,000, Shinhan Time Mezzanine Blind New Technology Fund for KRW 1,500,000,000, Anda H KOSDAQ Venture Specialized Investment Criminal Equity Trust No. 3 for KRW 2,000,000,000, Anda H The banks 2 Professional Investment Criminal Investment Trust for KRW 2,000,000,000, Anda Cruise Specialized Investment Criminal Equity Trust No. 1 and
Andacruz Specialized Investment Detective Private Equity Trust No.2 for KRW 700,000,000, Anda Voyager Specialized Investment Criminal Equity Trust No. 1 for KRW 300,000,000, NH Absolute Mezzanine General Private Equity Trust No. 2 for KRW 1,000,000,000, NH Absolute KOSDAQ Venture Mezzanine Professional Investment Private Equity Trust No. 1 for KRW 2,000,000,000, Suseong The banks 2 Specialized Investment Criminal Investment Trust for KRW 1,000,000,000, Suseong KOSDAQ Venture B9 Specialized Investment Criminal Equity Investment Trust for KRW 500,000,000,
GB A The banks 2 General Private Equity Trust (Professional Investor) for KRW 1,000,000,000, GBA Coven-V General Private Equity Trust for KRW 500,000,000, GBA Coven-i General Private Equity Trust (Professional Investor) for KRW 500,000,000, DS Design.? Professional Investment Type Private Equity Trust for KRW 1,000,000,000, Orion The banks 1 Professional Investment Private Equity Trust for KRW 600,000,000, Orion Luxury KOSDAQ Venture Professional Investment Private Equity Trust No. 49 for KRW 400,000,000, Shinhan Investment Corp., Investment Arm for KRW 3,000,000,000, Hanyang Securities Co., Ltd., Investment Arm for KRW 2,500,000,000, Mirae Asset Capital Co,Ltd., Investment Arm for KRW 2,000,000,000, BNK Investment & Securities Co., Ltd. for KRW 1,000,000,000, Mirae Asset Daewoo Co., Ltd., Investment Arm for KRW 2,000,000,000, Cornerstone Investment Partners Co., Ltd. for KRW 1,000,000,000. The bond carries zero coupon rate of interest and will mature on November 24, 2026. The bonds are fully convertible into 1,372,809 shares at conversion price of KRW 21,853 per share. The conversion period will start from November 24, 2022 and ends on October 24, 2026. The transaction is expected to close on November 24, 2021. The transaction has been approved by the board of directors of the company.
Seoulin Bioscience Co., Ltd is a Korea-based company engaged in the developing and manufacturing of basic equipment for bio research. The Company mainly engages in research and development of reagents, such as deoxyribonucleic acid (DNA) chips, which are used for gene therapy, clinical diagnosis, organs transplantation and biopsy; stem cells, which are used for treatment of incurable diseases, Alzheimer disease and others, and next-generation biotechnology drugs. The company supplies its products under the brand name MyLab. It also imports bio research equipment from Thermo Fisher, Affymetrix, Sarstedt and others, and markets in the domestic market. In addition, the Company engages in the real estate rental business.
SEOULIN BIOSCIENCE CO.,LTD. 
